• 1. Condensation of β-dicarbonyl compounds with halogenopyridinecarboxylic acids. A convenient synthesis of some naphthyridine derivatives
  D. E. Ames,W. D. Dodds J. Chem. Soc. Perkin Trans. 1 1972 705
• 2. Naphthyridines. Structure, physicochemical properties and general methods of synthesis
  Viktor P. Litvinov,S V. Roman,Vladimir D. Dyachenko Russ. Chem. Rev. 2000 69 201

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Recent Advances in the Application of 3-Bromopyridine-4-carboxylic Acid (CAS: 13959-02-9) in Chemical Biology and Pharmaceutical Research

3-Bromopyridine-4-carboxylic acid (CAS: 13959-02-9) is a versatile chemical building block that has garnered significant attention in recent years due to its potential applications in drug discovery and chemical biology. This heterocyclic compound, characterized by a pyridine ring substituted with a bromine atom and a carboxylic acid group, serves as a critical intermediate in the synthesis of various pharmacologically active molecules. Recent studies have explored its utility in the development of kinase inhibitors, antimicrobial agents, and other therapeutic compounds, highlighting its importance in modern medicinal chemistry.

One of the most notable advancements involves the use of 3-bromopyridine-4-carboxylic acid as a precursor in the synthesis of novel kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in the construction of selective JAK2 inhibitors, which are promising candidates for the treatment of myeloproliferative disorders. The bromine atom at the 3-position allows for further functionalization via cross-coupling reactions, enabling the introduction of diverse pharmacophores to optimize biological activity and selectivity.

In addition to its role in kinase inhibitor development, 3-bromopyridine-4-carboxylic acid has been employed in the design of antimicrobial agents. Researchers have recently reported its incorporation into hybrid molecules targeting bacterial efflux pumps, a mechanism associated with multidrug resistance. These hybrids exhibit potent activity against resistant strains of Staphylococcus aureus and Escherichia coli, as evidenced by in vitro and in vivo studies. The carboxylic acid moiety facilitates the formation of salt bridges with key residues in the target proteins, enhancing binding affinity.

Beyond therapeutic applications, 3-bromopyridine-4-carboxylic acid has found use in chemical biology as a tool for protein labeling and modification. A 2024 study in ACS Chemical Biology detailed its application in the site-specific modification of lysine residues via nucleophilic aromatic substitution (SNAr). This approach enables the introduction of bioorthogonal handles for subsequent conjugation with fluorescent probes or affinity tags, providing a powerful strategy for studying protein-protein interactions and cellular localization.

Despite these promising developments, challenges remain in the scalable synthesis and derivatization of 3-bromopyridine-4-carboxylic acid. Recent efforts have focused on optimizing catalytic systems for its production, with particular emphasis on minimizing byproducts and improving yields. Advances in flow chemistry and photoredox catalysis have shown potential in addressing these issues, paving the way for broader adoption of this compound in industrial and academic settings.

In conclusion, 3-bromopyridine-4-carboxylic acid (CAS: 13959-02-9) continues to emerge as a valuable scaffold in pharmaceutical research and chemical biology. Its unique structural features enable diverse applications, from drug discovery to protein engineering. Future research is expected to further explore its potential, particularly in the context of targeted therapies and precision medicine. As synthetic methodologies evolve, this compound is poised to play an increasingly prominent role in addressing unmet medical needs.

• 70201-42-2(3,5-Dibromopyridine-4-carbaldehyde)
• 70201-43-3(3-bromopyridine-4-carbaldehyde)
• 13958-91-3(3,5-dibromopyridine-4-carboxylic acid)
• 146679-66-5((3-Bromopyridin-4-YL)methanol)
• 90325-36-3(5-Bromopyridine-3,4-dicarboxylic acid)
• 942473-59-8(2,5-dibromopyridine-4-carboxylic acid)
• 59786-31-1(methyl 3-bromopyridine-4-carboxylate)
• 1214375-76-4(Ethyl 3,5-dibromoisonicotinate)
• 1020056-98-7(2,3-Dibromoisonicotinic Acid)
• 13959-01-8(Ethyl 3-Bromopyridine-4-carboxylate)